Anna Parackal
Papers
1
Total Citations
22
H-Index
1
About
Dr. Anna Parackal is a health economist whose research focuses on the economic evaluation of surgical technologies, particularly in oncology and urology. Her most cited work provides a rigorous cost-effectiveness analysis of robot-assisted radical prostatectomy (RARP) compared to open surgery for prostate cancer treatment in Ontario, Canada. This study, published in 2020 with 22 citations, directly addresses a critical policy debate: why health technology assessments in different Canadian provinces yielded conflicting recommendations. By modeling long-term costs and quality-adjusted life years, Dr. Parackal’s research helps clarify whether the substantial upfront investment in robotic surgery is justified by improved patient outcomes. Her contributions are vital for evidence-based decision-making in healthcare resource allocation, influencing how hospitals and governments adopt expensive surgical innovations. Through her work, Dr. Parackal bridges the gap between clinical practice and health policy, ensuring that economic considerations are transparently integrated into cancer care planning. Her analyses empower clinicians and administrators to make informed choices that balance patient benefit with fiscal responsibility.
Research Focus
Key Achievements
Top Papers
- 1